Yasmeen Abouelhassan

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also affiliated with Hartford Hospital, Hartford Financial Services (United States)

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicineChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents”.

A Modular Synthetic Route Involving N-Aryl-2-nitrosoaniline Intermediates Leads to a New Series of 3-Substituted Halogenated Phenazine Antibacterial Agents

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00168

N/A

0DataRank · unranked

34 citations

Shivani Kundra, Michaelle Chojnacki, Ke Liu, Marisa A. Fuse, Yasmeen Abouelhassan +11 more

Transcript Profiling of Nitroxoline-Treated Biofilms Shows Rapid Up-regulation of Iron Acquisition Gene Clusters

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00206

N/A

0DataRank · unranked

13 citations

Yasmeen Abouelhassan, Yanping Zhang, Shouguang Jin, Robert W. Huigens, Ke Liu

In vivo pharmacokinetics and pharmacodynamics of ceftibuten/ledaborbactam, a novel oral β-lactam/β-lactamase inhibitor combination

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac359

N/A

0DataRank · unranked

12 citations

Lindsay M. Avery, Yasmeen Abouelhassan, Tomefa E. Asempa, Andrew J Fratoni